Kyle T Matschke

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Cardiac Resynchronization Therapy

Emergency Department

Heart Rate Variability

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)